Baidu
map

钟南山谈广州医改:应走出“三性”

2015-08-20 刘宇雄 信息时报

8月19日至21日,广东省人大常委会组织广东选出的全国人大代表开展专题调研。昨日,在“深化医药卫生体制改革”专题视察座谈会上,全国人大代表、呼吸疾病国家重点实验室主任钟南山谈当前医改时指出,广州的医改路应该走出“公益性、均等性和先进性”。“取消药品加成后补贴太少”昨日,省卫生计生委党组书记骆文智汇报时表示,全省58个县(市)153家县级公立医院均要参加改革并取消药品加成,不再靠“卖药”营收。医院要

8月19日至21日,广东省人大常委会组织广东选出的全国人大代表开展专题调研。昨日,在“深化医药卫生体制改革”专题视察座谈会上,全国人大代表、呼吸疾病国家重点实验室主任钟南山谈当前医改时指出,广州的医改路应该走出“公益性、均等性和先进性”。

“取消药品加成后补贴太少”

昨日,省卫生计生委党组书记骆文智汇报时表示,全省58个县(市)153家县级公立医院均要参加改革并取消药品加成,不再靠“卖药”营收。

医院要生存,所减少的药品收入怎么解决?按照目前的规定,80%由调整医疗服务价格补偿,10%由各级财政补助,10%由医院自行消化。

“公立医院的改革我觉得是没有突破!”钟南山认为,取消加成后,由各级财政补助的10%“实在是极少极少”,八成通过调整医疗服务价格来补偿就意味着看病支出依旧转移到了个人。

“公立医院最关心营收问题”

广州市副市长欧阳卫民在汇报广州医改总体情况时指出,广州已“初步建立其公益性管理体制、竞争性用人机制、激励性分配机制、多渠道补偿机制等新的运行机制”。

“我同意后三点,但对于第一条不同意。”钟南山表示,目前很多公立医院的院长最关心的还是医院的营业收入问题。他指出,目前广州三甲医院医务人员的工资大概是普通医院人员的3到4倍,但当中工资只有20%~30%是政府支持,“如果医院要靠政府这点钱让医务人员干活我看是不可能,这也使得现在医院收入更多趋向于药费,以及尽量多看病人。”

“广州医改先往公益性突破”

谈到广州医改方向,钟南山指出,首先要往公益性方向突破,政府需要认真考虑这点。其次是要做到“均等性”,钟南山以全科医生为例,“我记得以前有报告说到广州的全科医生每一万人只有0.73个,而现在每万人有2.1个。但按照文件里说要8人/万人口的编制标准配备,为什么达不到?报告说是编制短缺的原因,但我认为是(医生的)素质问题。”

钟南山还指出,广州作为一个中心城市,在医改的路上还要体现出它的先进性。

钟南山谈广州医改

“公益性、均等性、先进性”

公益性

有领导曾提出,一是政府要对公益医院负起责任,二是政府要消除公立医院的逐利性,我觉得非常切中要害。

均等性

广州是全国拥有高等医学院校最多的城市,但基层医院里还是缺人,这就说明医生之间的均等性机制没有真正建立起来。

先进性

我现在还看门诊,其中60%、70%的病人都来自外市,一些甚至来自全国,我觉得作为广州来说,就应该起到这个作用。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=71600, encodeId=84f1e16008a, content=改革任务很重啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccc11622300, createdName=yangcristina, createdTime=Sat Mar 19 00:02:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57744, encodeId=964e5e744f0, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57745, encodeId=932f5e74566, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57746, encodeId=96b05e746c6, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57747, encodeId=bca95e7473c, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57748, encodeId=cd325e74888, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57749, encodeId=1dcc5e7494e, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286523, encodeId=995f128652322, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Aug 22 05:37:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
    2016-03-19 yangcristina

    改革任务很重啊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=71600, encodeId=84f1e16008a, content=改革任务很重啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccc11622300, createdName=yangcristina, createdTime=Sat Mar 19 00:02:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57744, encodeId=964e5e744f0, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57745, encodeId=932f5e74566, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57746, encodeId=96b05e746c6, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57747, encodeId=bca95e7473c, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57748, encodeId=cd325e74888, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57749, encodeId=1dcc5e7494e, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286523, encodeId=995f128652322, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Aug 22 05:37:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
    2016-01-16 medsic

    不晓得实施后会变成什么样了,

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=71600, encodeId=84f1e16008a, content=改革任务很重啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccc11622300, createdName=yangcristina, createdTime=Sat Mar 19 00:02:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57744, encodeId=964e5e744f0, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57745, encodeId=932f5e74566, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57746, encodeId=96b05e746c6, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57747, encodeId=bca95e7473c, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57748, encodeId=cd325e74888, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57749, encodeId=1dcc5e7494e, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286523, encodeId=995f128652322, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Aug 22 05:37:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
    2016-01-16 medsic

    不晓得实施后会变成什么样了,

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=71600, encodeId=84f1e16008a, content=改革任务很重啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccc11622300, createdName=yangcristina, createdTime=Sat Mar 19 00:02:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57744, encodeId=964e5e744f0, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57745, encodeId=932f5e74566, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57746, encodeId=96b05e746c6, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57747, encodeId=bca95e7473c, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57748, encodeId=cd325e74888, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57749, encodeId=1dcc5e7494e, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286523, encodeId=995f128652322, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Aug 22 05:37:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
    2016-01-16 medsic

    哦,

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=71600, encodeId=84f1e16008a, content=改革任务很重啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccc11622300, createdName=yangcristina, createdTime=Sat Mar 19 00:02:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57744, encodeId=964e5e744f0, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57745, encodeId=932f5e74566, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57746, encodeId=96b05e746c6, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57747, encodeId=bca95e7473c, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57748, encodeId=cd325e74888, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57749, encodeId=1dcc5e7494e, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286523, encodeId=995f128652322, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Aug 22 05:37:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
    2016-01-16 medsic

    哦,

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=71600, encodeId=84f1e16008a, content=改革任务很重啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccc11622300, createdName=yangcristina, createdTime=Sat Mar 19 00:02:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57744, encodeId=964e5e744f0, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57745, encodeId=932f5e74566, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57746, encodeId=96b05e746c6, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57747, encodeId=bca95e7473c, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57748, encodeId=cd325e74888, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57749, encodeId=1dcc5e7494e, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286523, encodeId=995f128652322, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Aug 22 05:37:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
    2016-01-16 medsic

    了解,

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=71600, encodeId=84f1e16008a, content=改革任务很重啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccc11622300, createdName=yangcristina, createdTime=Sat Mar 19 00:02:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57744, encodeId=964e5e744f0, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57745, encodeId=932f5e74566, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57746, encodeId=96b05e746c6, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57747, encodeId=bca95e7473c, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57748, encodeId=cd325e74888, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57749, encodeId=1dcc5e7494e, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286523, encodeId=995f128652322, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Aug 22 05:37:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
    2016-01-16 medsic

    了解,

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=71600, encodeId=84f1e16008a, content=改革任务很重啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccc11622300, createdName=yangcristina, createdTime=Sat Mar 19 00:02:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57744, encodeId=964e5e744f0, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57745, encodeId=932f5e74566, content=不晓得实施后会变成什么样了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57746, encodeId=96b05e746c6, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57747, encodeId=bca95e7473c, content=哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57748, encodeId=cd325e74888, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57749, encodeId=1dcc5e7494e, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 16 00:30:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286523, encodeId=995f128652322, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Aug 22 05:37:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
    2015-08-22 tidiq

相关资讯

Chest:钟南山等研究发现罗氟司特为重度至极重度亚裔COPD患者理想的治疗药物

罗氟司特是可用于治疗慢性阻塞性肺疾病(COPD)的唯一口服磷酸二酯酶4抑制剂。以往有关该药的研究主要在欧洲和北美国家的人群中进行。为了明确在以华人为主的此类人群中,使用罗氟司特的有效性和安全性。来自广州医科大学第一附属医院、广州呼吸疾病研究所的钟南山研究团队进行了一项研究,研究结果在线发表于2013年10月17日的CHEST杂志上。结果显示:罗氟司特治疗能明显改善亚裔COPD患者的肺功能,并具有很

钟南山:复旦大学已研制出MERS病毒抗体

对话人物钟南山,中国工程院院士、广州医学院广州呼吸疾病研究所所长,目前担任广东省防控中东呼吸综合征疫情专家组组长。对话背景我国首例输入性MERS患者治疗进展如何?MERS病毒离我们普通人远吗?为什么近几年出现的传染病不断增加?华商报记者昨日专访了钟南山。国内首例MERS患者情况如何?康复较好 仍密切观察监测华商报:目前在广东惠州接受隔离治疗的我国首例输入性MERS患者,他的病情现在如何?钟南山

钟南山:个案显示H7N9可能有限度人传人

10月17日,中国工程院院士、著名呼吸病学专家钟南山在香港中文大学进行了一场名为“从非典到H7N9禽流感——中国呼吸疾病感染控制”的主题演讲。会上,钟南山从目前掌握的人感染H7N9禽流感的病例分析,结合相关的动物实验研究结果,认为H7N9病毒可能存在有限的人传人。 钟南山在讲座中提到了一项动物实验,科研人员选取了细胞受体与人类十分接近的雪貂,将两组雪貂分别放入相隔很近

第三次医事法学学会会议12 2013 :钟南山称广东正研究PM2.5与肺癌发病率关系

第二届南方医事法学高峰论坛暨广东省医学会第三次医事法学学会会议12月14至15日在广州举行。出席会议的中国工程院院士钟南山接受采访时表示,现在还没办法完全认定北上广呼吸系统疾病异常增加率上升,元凶是PM2.5的说法。但是肺癌的发病率跟灰霾是有紧密关系的。 钟南山指出,目前国内还没有权威的数据证明PM2.5和肺癌的关系,相关的研究也正在进行。但是欧美一些国家的长达十几二十年的研究是证明灰霾会引起肺

钟南山在两会:语出惊人,但一半错误一半合理

一、钟南山谈医疗反腐:医护精英落马是必然结果---你认同吗?“一些医疗精英的落马,是医疗领域走市场化路线之后的必然结果。”3月5日晚,在十二届全国人大三次会议广东代表团住地举行的集体采访会上,中国工程院院士、广州呼吸疾病研究所所长钟南山代表在回答本报记者提问时这样表示。在回答本报记者关于如何看待医疗系统的精英也在“打老虎、拍苍蝇”的过程中落马的问题时,他说:“我不觉得奇怪。基本上所有大医院都是

钟南山:淮河以北人均预期寿命短了5年多

  钟南山回应媒体提出的雾霾危害与治理问题。 南都记者 陈辉 摄 全国人大代表、中国工程院院士钟南山再次被媒体追问雾霾危害与治理。关于雾霾对人体健康的影响,钟南山表示,从国内研究来看,只有少数可信论据,主要引发的是人的心血管和呼吸系统疾病。去年夏天发表在《美国科学院院报》上,关于淮河以南以北的降尘浓度研究显示,由于有供暖燃煤的区别,淮河以北预期寿命短了5 .52年。因此,灰霾浓度每立方米增加

Baidu
map
Baidu
map
Baidu
map